Lincoln Fine Ingredients

Univar USA among the leading chemical distributors in the nation, providing chemicals and related chemical distribution services to the electronics, energy sector, food, personal care, pest control, pharmaceutical and waster management industries. Univar USA was founded in 1924 as a brokerage that bought and sold naval stores, paint, raw materials and cotton linters in the Pacific Northwest. The company moved into the chemical distribution business and grew throughout the West and into the Eastern United States. Univar entered the Canadian market in 1950 and Europe in 1991. Univar USA is Univar s chemical distribution subsidiary in the United States. Univar is a Dutch company listed on the Euronext Amsterdam stock exchange as UNIVR. Univar USA distributes chemical products and services from more than 80 locations throughout the United States, including one in Providence, R.I. Univar USA is headquartered in Kirkland, Wash.

Warehouse Distributors of New England is a reputable company based in Seekonk, MA, specializing in the distribution of a wide range of automotive products and services. With a dedicated team of professionals and a comprehensive distribution area, they offer top-notch machine repair, battery, brake, climate, cooling system, diesel fuel system, drive line, engine, gasoline fuel system, power steering, specialty, and transmission programs. Additionally, Warehouse Distributors of New England provides BG pre-owned vehicle protection, BG on the road services, BG certified SmartVMA, BG reminder service, and lifetime BG protection plans. Their commitment to customer satisfaction is evident through their competitive product analysis, video library, tech tips, technical O.E. manufacturer bulletins, spec tech safety data sheets, testimonials, and links to find a shop or schedule training.Generated from the website

Eloxx Pharmaceutical is a cutting-edge biopharmaceutical company based in Waltham, MA, specializing in the development of small molecule genetic therapies. With a scientific focus on correcting nonsense mutations and ribosomal mutations, their platform technologies have the potential to revolutionize the treatment of rare genetic diseases and cancer. Driven by their commitment to innovation, Eloxx is currently focused on developing CELX-02, a novel therapy for Alport Syndrome, a rare kidney disease. Their pipeline also includes promising treatments for other conditions such as RDEB, JEB, and FAP, all targeting the underlying genetic defects responsible for these diseases. With a strong emphasis on scientific research and development, Eloxx Pharmaceuticals is poised to make a significant impact in the field of genetic medicine.Generated from the website